The Ministry of Health and Child Care has urged members of the public using Nifedipine 10 mg tablets to check their medicine packaging following the recall of two specific batches manufactured by Remedica Ltd.
Speaking on the matter, recently, Ministry spokesperson, Donald Mujiri, said the recall was a legitimate regulatory action by the Medicines Control Authority of Zimbabwe (MCAZ) and was part of ongoing efforts to safeguard the quality and safety of medicines available in the country.
“The MCAZ notice currently circulating concerning the recall of specific batches of Nifedipine 10 mg tablets is genuine and forms part of the Authority’s routine regulatory and post-market surveillance activities.
“The affected batches were 112033 and 117367, patients who discover that they have medicines from either batch should return them to the pharmacy or health facility where they obtained them,” Mujiri added.
He emphasised that MCAZ remained the country’s statutory authority responsible for regulating medicines and ensuring that they met the required standards of quality, safety and efficacy.
“The recall followed quality monitoring by MCAZ, which subsequently triggered regulatory action against the two affected batches,” he said.
Mujiri also cautioned members of the public against relying on unverified information circulating on social media platforms and WhatsApp, particularly messages that may cause patients to abruptly discontinue prescribed medication.
“Patients should not stop or change prescribed treatment solely on the basis of such messages. Those with concerns to consult qualified healthcare professionals or contact MCAZ directly for clarification,” Mujiri added.
The clarification comes amid growing circulation of medicine-related information on social media, where unverified claims can create confusion and potentially lead to inappropriate changes in treatment.
